Chee Kong Choo - 31 Mar 2023 Form 3 Insider Report for CytoMed Therapeutics Ltd (GDTC)

Role
Director, 10%+ Owner
Signature
/s/ Chee Kong Choo
Issuer symbol
GDTC
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
3
Filing time
14 Apr 2023, 16:59:09 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GDTC Ordinary Shares, no par value per share 2,559,482 31 Mar 2023 See footnote F1
holding GDTC Ordinary Shares, no par value per share 410,515 31 Mar 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 2,559,482 Ordinary Shares held by Glorious Finance Limited ("Glorious Finance"). Mr. CHOO Chee Kong does not directly hold any shares in our Company but is deemed to beneficially own the shares held by Glorious Finance as indicated in the table above. Mr. CHOO Chee Kong owns 55.0% of shares in Glorious Finance. Glorious Finance is a major shareholder of the Company.
F2 Consists of 410,515 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. CHOO Chee Kong does not directly hold any shares in our Company but is deemed to beneficially own the shares held by EP Capital as indicated in the table above. Mr. CHOO Chee Kong owns 100.0% of shares in EP Capital.